Healthcare -
Biotechnology - NASDAQ - US
$ 585.315
-0.297 %
$ 62.6 B
Market Cap
14.64
P/E
REGN - OTHER CURRENT LIABILITIES
Other Current Liabilities REGN - Regeneron Pharmaceuticals, Inc.
2.31 B
LAST VALUE
5.63%
2 YEAR CAGR
7.27%
5 YEAR CAGR
17.01%
10 YEAR CAGR